- £2.98bn
- £2.87bn
- £985.30m
- 97
- 16
- 57
- 59
2019 July 31st | 2020 July 31st | C2021 July 31st | 2022 July 31st | 2023 July 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 992 | 1,077 | 784 | 1,078 | 985 |
Cost of Revenue | |||||
Gross Profit | 211 | 236 | 276 | 327 | 374 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Total Operating Expenses | 907 | 983 | 665 | 942 | 844 |
Operating Profit | 84.5 | 93.7 | 119 | 136 | 141 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 84.8 | 93.6 | 119 | 136 | 142 |
Provision for Income Taxes | |||||
Net Income After Taxes | 68.5 | 75.7 | 96.2 | 110 | 112 |
Net Income Before Extraordinary Items | |||||
Net Income | 68.5 | 75.7 | 96.2 | 110 | 112 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 68.5 | 75.7 | 96.2 | 110 | 112 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.344 | 0.38 | 0.482 | 0.553 | 0.56 |
Dividends per Share | |||||
Special Dividends per Share |